Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
AstraZeneca
Medtronic
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tyramine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Tyramine?

Tyramine is an investigational drug.

There have been 16 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 2nd 2018.

The most common disease conditions in clinical trials are Hypercholesterolemia, Hyperlipoproteinemia Type II, and Depressive Disorder. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and Boehringer Ingelheim.

Recent Clinical Trials for Tyramine
TitleSponsorPhase
A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel SyndromePharmascience Inc.Phase 2
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood PressureBoehringer IngelheimPhase 1
Coenzyme Q10 and Meclofenoxate in Hepatic EncephalopathyZagazig UniversityN/A

See all Tyramine clinical trials

Clinical Trial Summary for Tyramine

Top disease conditions for Tyramine
Top clinical trial sponsors for Tyramine

See all Tyramine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
McKinsey
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.